Hydroxychloroquine one of several drugs cited in recent days as being possibly effective against coronavirus; Israeli firm says it will provide as many as possible at no cost.
The company said six million doses will be delivered to US hospitals by March 31, and more than ten million in a month.
Israeli generic drug giant Teva announced Friday that it will provide ten million doses of its anti-malarial drug hydroxychloroquine, which could potentially prove effective in fighting the coronavirus pandemic, to US hospitals free of charge. The company said six million doses will be delivered to US hospitals by March 31, and more than ten million in a month. “We are committed to helping to supply as many tablets as possible as demand for this treatment accelerates at no cost,” Teva executive vice president Brendan O’Grady said. Get The Times of Israel’s Daily Edition by email and never miss our top stories Free Sign Up.
Comments are closed.